Titre :
  • Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial.
Auteur : Biganzoli, Laura ; Cufer, T ; Bruning, Peter ; Coleman, R ; Duchateau, L ; Rapoport, Benjamin ; Nooij, Marianne ; Delhaye, François ; Miles, David J C ; Sulkes, Aaron ; Hamilton, Andrew ; Piccart-Gebhart, Martine
Informations sur la publication : Cancer, 97, 1, (page 40-45)
Statut de publication : Publié, 2003-01
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Cardiac toxicity
Doxorubicin
Multicenter trials
Paclitaxel
Mots-clés MeSH : Adenocarcinoma -- drug therapy
Adenocarcinoma -- secondary
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Cyclophosphamide -- administration & dosage
Disease Progression
Disease-Free Survival
Doxorubicin -- administration & dosage
Female
Follow-Up Studies
Heart -- drug effects
Humans
Middle Aged
Paclitaxel -- administration & dosage
Risk Factors
Safety
Survival Rate
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:0008-543X 
info:doi/10.1002/cncr.10914
info:pmid/12491503